Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Ann Rheum Dis. 2012 Feb 2;71(8):1335–1342. doi: 10.1136/annrheumdis-2011-200546

Table 1.

Baseline Characteristics of Normal vs. BoPAP vs. Resting PH groups who underwent RHC

TOTAL(N=206) NORMAL(N=35) BORDERLINE (N=28) Resting PH (N=143)
Mean(SD) Median Mean(SD) Median Mean(SD) Median Mean(SD) Median
Age, years 57.2(11.6) 58.0 55.7(12.6) 57.0 54.8 (10.4) 55.0 58.0(11.5) 59.0
Female, N(%) 171(85.1) 28(80.0) 24(85.7) 119(85.6)
Scleroderma subtype, N(%)
 Limited 129(62.6) 22(62.9) 16(61.5) 91(62.8)
 Diffuse 66(32.0) 11(29.7) 9(34.6) 46(31.7)
 Unclassified 11(5.3) 2(5.4) 1(3.9) 6(5.5)
Disease Duration (yrs)
From onset of Raynaud phenomenon 11.6(10.3) 8.5 10.7(8.5) 7.8 8.6(6.1) 7.3 12.4(11.2) 9.0
From onset of non-Raynaud symptom 8.7(7.3) 6.7 7.8(5.4) 6.8 8.1(6.0) 6.2 9.1(8.0) 6.7
From first SSc diagnosis 7.1 (8.1) 4.5 5.1(4.5) 3.6 5.9(6.2) 3.3 7.8(9.0) 5.3
Race, N(%)
 Caucasian 140(69.6) 22(62.9) 17(60.7) 101(73.2)
 Hispanic 15(7.5) 5(14.3) 2(7.1) 8(5.8)
 African-American 37(18.4) 6(17.1) 7(25.0) 24(17.4)
 Other 9(4.5) 2(5.7) 2(7.1) 5(3.6)
HAQ-DI score(0–3) 0.9(0.8) 0.8 0.8(0.8) 0.5 0.7(0.6) 0.6 1.0(0.8) 1.0
VAS Breathing score(0–3) 1.2(0.9) 1.0 0.8(0.7) 0.6 0.9(0.9) 0.5 1.3(0.9) 1.5
VAS Raynaud’s score(0–3) 0.6(0.8) 0.3 0.6(0.7) 0.4 0.4(0.7) 0.1 0.7(0.8) 0.3
VAS Finger ulcers score(0–3) 0.5(0.8) 0.1 0.4(0.7) 0.1 0.3(0.6) 0 0.5(0.8) 0.1
VAS Overall score(0–3) 1.2(0.8) 1.2 1.0(0.8) 1.0 0.9(0.8) 0.8 1.4(0.8) 1.4
UCSD score(0–5) 1.6(1.1) 1.5 1.2(0.8) 1.2 1.4(1.1) 1.1 1.8(1.2) 1.7
SF-36 PCS 30.7(10.8) 28.4 33.6(9.6) 31.1 36.8(13.2) 37.9 28.5(9.9) 27.5
SF-36 MCS 48.1(11.3) 49.6 49.6(12.8) 54.0 50.3(9.4) 49.9 47.2(11.2) 49.0

p> 0.05 for all comparisons; HAQ-DI: Health Assessment Questionnaire – Disease Index; VAS: Visual Analogue Scale, UCSD: University of California at San Diego; SF-36: Short form 36; PCS: Physical Component Summery; MCS: Mental Component Summery